NVO Drifts Down on Deal
Novo Nordisk is slipping moderately on quiet volume after announcing a biotech acquisition deal, with the market reacting calmly and the stock drifting lower without panic.
Sources: https://www.rttnews.com/3696229/weekly-buzz-ew-abbv-mirm-score-fda-wins-azn-nvo-strike-deals-lly-kod-report-data.aspx, https://www.gekko.app/stocks/nvo, https://www.finanznachri
Ezbrisk weighs each event against the market reaction and publishes a verdict with an overreaction reading. How the methodology works